山推股份(000680.SZ)擬在原在建研發大樓的基礎上 投3億元建協同研究院
格隆匯11月18日丨山推股份(000680.SZ)公佈,為強化公司優勢資源協同,促進由營銷驅動向產品驅動轉型,加快產品、市場、業務三大結構調整,適應物聯網技術發展帶來的施工工法變化,打造產品競爭優勢和一體化施工方案及設備提供的競爭優勢。公司擬在原在建研發大樓的基礎上,投資建設工程機械協同研究院(“協同研究院”)。項目總投入約為3億元,項目建設期為一年,建成集研發、試驗等功能於一體的研發平台。
協同研究院項目新增用地面積約為6.5萬㎡,規劃總建築面積約6.7萬㎡,建設項目包括整機實驗室、產品體驗室等,打造成為適應全球化競爭、多地協同,支持敏捷創新的國際一流工程機械研發、試製、測試、驗證基地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.